Abstract

BackgroundTwo Kato-Katz thick smears (Kato-Katzs) from a single stool are currently recommended for diagnosing Schistosoma mansoni infections to map areas for intervention. This ‘gold standard’ has low sensitivity at low infection intensities. The urine point-of-care circulating cathodic antigen test (POC-CCA) is potentially more sensitive but how accurately they detect S. mansoni after repeated praziquantel treatments, their suitability for measuring drug efficacy and their correlation with egg counts remain to be fully understood. We compared the accuracies of one to six Kato-Katzs and one POC-CCA for the diagnosis of S. mansoni in primary-school children who have received zero to ten praziquantel treatments. We determined the impact each diagnostic approach may have on monitoring and evaluation (M&E) and drug-efficacy findings.Method/Principle FindingsIn a high S. mansoni endemic area of Uganda, three days of consecutive stool samples were collected from primary school-aged children (six - 12 years) at five time-points in year one: baseline, one-week-post-, four-weeks-post-, six-months-post-, and six-months-one-week-post-praziquantel and three time-points in years two and three: pre-, one-week-post- and four-weeks-post-praziquantel-treatment/retreatment (n = 1065). Two Kato-Katzs were performed on each stool. In parallel, one urine sample was collected and a single POC-CCA evaluated per child at each time-point in year one (n = 367). At baseline, diagnosis by two Kato-Katzs (sensitivity = 98.6%) or one POC-CCA (sensitivity = 91.7%, specificity = 75.0%) accurately predicted S. mansoni infections. However, one year later, a minimum of three Kato-Katzs, and two years later, five Kato-Katzs were required for accurate diagnosis (sensitivity >90%) and drug-efficacy evaluation. The POC-CCA was as sensitive as six Kato-Katzs four-weeks-post and six-months-post-treatment, if trace readings were classified as positive.Conclusions/SignificanceSix Kato-Katzs (two/stool from three stools) and/or one POC-CCA are required for M&E or drug-efficacy studies. Although unable to measure egg reduction rates, one POC-CCA appears to be more sensitive than six Kato-Katzs at four-weeks-post-praziquantel (drug efficacy) and six-months-post-praziquantel (M&E).

Highlights

  • Schistosomiasis remains a major public health concern despite praziquantel reaching over 30 million people in endemic areas in 2013 [1]

  • Our results demonstrate that two Kato-Katzs accurately detect S. mansoni infection pre-treatment, but at least three days of two Kato-Katzs per stool or one point-of-care circulating cathodic antigen test (POC-cathodic antigens (CCA)) are required for annual monitoring and treatment evaluation and/or drug-efficacy studies

  • Baseline S. mansoni prevalence (x2 = 0.38, d.f. = 2, p = 0.83) and eggs per gram of stool (EPG) intensity (Kruskal-Wallis: H = 3.416, d.f. = 2, p = 0.18) were not significantly different between schools and all statistics were performed on the combined data

Read more

Summary

Introduction

Schistosomiasis remains a major public health concern despite praziquantel reaching over 30 million people in endemic areas in 2013 [1]. The WHO recommends two Kato-Katz thick smears (KatoKatzs) from a single stool [14] for Schistosoma mansoni diagnosis to determine prevalence to map areas for control interventions [15]. In Brazil, where M&E programs use only one Kato-Katz, S. mansoni prevalence has been significantly underestimated in low intensity regions [22,23]. Two Kato-Katz thick smears (Kato-Katzs) from a single stool are currently recommended for diagnosing Schistosoma mansoni infections to map areas for intervention. This ‘gold standard’ has low sensitivity at low infection intensities. We determined the impact each diagnostic approach may have on monitoring and evaluation (M&E) and drugefficacy findings

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call